Evidera
Kang Kang is a seasoned professional in the field of Modeling and Simulation, currently serving as a Research Associate II at Evidera since August 2022, following a progression from Research Associate I. Prior experience includes multiple roles as both Teaching Assistant and Research Assistant at the University of Minnesota, spanning from January 2017 to August 2022. Kang Kang holds a Doctor of Philosophy (PhD) in Industrial and Systems Engineering from the University of Minnesota, obtained in August 2022, alongside a Bachelor of Science in Applied Mathematics and a Bachelor of Economics in Actuarial Science from Jilin University, completed between 2012 and 2016.
This person is not in any offices
Evidera
1 followers
Evidera is a business within Pharmaceutical Product Development, LLC, (PPD) a leading global contract research organization (CRO), and is the preeminent provider of evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products from early development through loss of exclusivity. We provide integrated scientific expertise and global operational capabilities to help you generate the evidence needed to optimize the market access and commercial potential of your products. Evidera was acquired by PPD in 2016 and originally created in 2013 as an independent company under the ownership of Symphony Technology Group following the acquisition of long-standing health economics, outcomes research, market access, epidemiology, and data analytics practices from United BioSource Corporation (UBC). Evidera has over 30 years of leadership and experience and its legacy brands include MEDTAP, Caro Research, Abt Bio-Pharmaceutical Solutions, MetaWorks, Total Healthcare Group, and Archimedes.